Literature DB >> 22050411

Autologous haematopoietic stem cell transplantation in multiple myeloma patients from ethnic minority groups in an equal access healthcare system.

Holger W Auner, Jiri Pavlu, Richard Szydlo, Chrissy Giles, Ed Kanfer, Donald Macdonald, David Marin, Dragana Milojkovic, Katayoun Rezvani, John M Goldman, Jane F Apperley, Ola Landgren, Amin Rahemtulla.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22050411      PMCID： PMC6896783          DOI： 10.1111/j.1365-2141.2011.08906.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  Equitable access to cancer services: A review of barriers to quality care.

Authors:  J S Mandelblatt; K R Yabroff; J F Kerner
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

2.  Access to hematopoietic stem cell transplantation: effect of race and sex.

Authors:  Thomas V Joshua; J Douglas Rizzo; Mei-Jie Zhang; Parameswaran N Hari; Seira Kurian; Marcelo Pasquini; Navneet S Majhail; Stephanie J Lee; Mary M Horowitz
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

3.  Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma.

Authors:  S Saraf; Y-H Chen; L C Dobogai; N Mahmud; D Peace; Y Saunthararajah; R Hoffman; S Chunduri; D Rondelli
Journal:  Bone Marrow Transplant       Date:  2006-05-08       Impact factor: 5.483

4.  Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.

Authors:  B Barlogie; S Jagannath; D H Vesole; S Naucke; B Cheson; S Mattox; D Bracy; S Salmon; J Jacobson; J Crowley; G Tricot
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113

5.  Racial disparities in incidence and outcome in multiple myeloma: a population-based study.

Authors:  Adam J Waxman; Pamela J Mink; Susan S Devesa; William F Anderson; Brendan M Weiss; Sigurdur Y Kristinsson; Katherine A McGlynn; Ola Landgren
Journal:  Blood       Date:  2010-09-07       Impact factor: 22.113

6.  A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

Authors:  M Attal; J L Harousseau; A M Stoppa; J J Sotto; J G Fuzibet; J F Rossi; P Casassus; H Maisonneuve; T Facon; N Ifrah; C Payen; R Bataille
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

7.  Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

Authors:  Parameswaran N Hari; Navneet S Majhail; Mei-Jie Zhang; Anna Hassebroek; Fareeha Siddiqui; Karen Ballen; Asad Bashey; Jenny Bird; Cesar O Freytes; John Gibson; Gregaory Hale; Leona Holmberg; Ram Kamble; Robert A Kyle; Hillard M Lazarus; Charles F LeMaistre; Fausto Loberiza; Angelo Maiolino; Philip L McCarthy; Gustavo Milone; Nancy Omondi; Donna E Reece; Matthew Seftel; Michael Trigg; David Vesole; Brendan Weiss; Peter Wiernik; Stephanie J Lee; J Douglas Rizzo; Paulette Mehta
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-14       Impact factor: 5.742

8.  Chemotherapy and survival for patients with multiple myeloma: findings from a large nationwide and population-based cohort.

Authors:  Nidhi Rohatgi; Xianglin L Du; Ann L Coker; Lemuel A Moye; Michael Wang; Shenying Fang
Journal:  Am J Clin Oncol       Date:  2007-10       Impact factor: 2.339

9.  Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

Authors:  J Bladé; D Samson; D Reece; J Apperley; B Björkstrand; G Gahrton; M Gertz; S Giralt; S Jagannath; D Vesole
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

10.  The impact of race on outcomes of autologous transplantation in patients with multiple myeloma.

Authors:  Pramvir S Verma; Robin S Howard; Brendan M Weiss
Journal:  Am J Hematol       Date:  2008-05       Impact factor: 10.047
  10 in total
  4 in total

1.  With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study.

Authors:  Nathanael R Fillmore; Sarvari V Yellapragada; Chizoba Ifeorah; Ansh Mehta; Diana Cirstea; Paul S White; Gustavo Rivero; Andrew Zimolzak; Saiju Pyarajan; Nhan Do; Mary Brophy; Nikhil C Munshi
Journal:  Blood       Date:  2019-04-19       Impact factor: 22.113

2.  Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications.

Authors:  E Dianne Pulte; Lei Nie; Nicole Gormley; Kirsten B Goldberg; Amy McKee; Ann Farrell; Richard Pazdur
Journal:  Blood Adv       Date:  2018-01-23

Review 3.  High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions.

Authors:  Patrick Hagen; Jiwang Zhang; Kevin Barton
Journal:  Blood Cancer J       Date:  2022-05-30       Impact factor: 9.812

4.  Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study.

Authors:  Samer Al Hadidi; Deepa Dongarwar; Hamisu M Salihu; Rammurti T Kamble; Premal Lulla; LaQuisa C Hill; George Carrum; Carlos A Ramos; Helen E Heslop; Saad Z Usmani
Journal:  Leuk Lymphoma       Date:  2021-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.